StreetInsider.com News Articles

Form 144 Chewy, Inc. Filed by: Billings William G.

Thu, 15 Oct 2026 12:53:00 -0400

si-local-file:///var/storage/secattach/20261015/27192413.html

Piper sees veterinary medicine challenges continuing through 2027

Tue, 06 Oct 2026 06:38:26 -0400

Investing.com -- Piper Sandler expects veterinary visits to decline 1% to 2% in 2026 and remain roughly flat to down 1% in 2027, with industry growth driven primarily by 3% to 5% pricing increases and limited service-intensity gains.

The firm noted that the veterinary market remains caught between resilient pricing and weak underlying volumes. Cumulative veterinary inflation since 2022 has likely impacted visits and could continue to affect visits for several more years due to lower puppy growth.

More than half of survey respondents now attribute weak industry growth primarily to demand rather than staffing issues. Veterinarians have become modestly more optimistic

Piper sees veterinary medicine challenges continuing through 2027

Tue, 06 Oct 2026 06:38:26 -0400

More than half of survey respondents now attribute weak industry growth primarily to demand rather than staffing issues. Veterinarians have become modestly more optimistic

Piper sees veterinary medicine challenges continuing through 2027

Tue, 06 Oct 2026 06:38:26 -0400

More than half of survey respondents now attribute weak industry growth primarily to demand rather than staffing issues. Veterinarians have become modestly more optimistic

Piper sees veterinary medicine challenges continuing through 2027

Tue, 06 Oct 2026 06:38:26 -0400

More than half of survey respondents now attribute weak industry growth primarily to demand rather than staffing issues. Veterinarians have become modestly more optimistic

Piper sees veterinary medicine challenges continuing through 2027

Tue, 06 Oct 2026 06:38:26 -0400

More than half of survey respondents now attribute weak industry growth primarily to demand rather than staffing issues. Veterinarians have become modestly more optimistic

Piper sees veterinary medicine challenges continuing through 2027

Tue, 06 Oct 2026 06:38:26 -0400

More than half of survey respondents now attribute weak industry growth primarily to demand rather than staffing issues. Veterinarians have become modestly more optimistic

Chewy Inc. (CHWY) PT Lowered to $28 at Mizuho

Tue, 29 Sep 2026 06:34:35 -0400

Mizuho analyst David Bellinger lowered the price target on Chewy Inc. (NYSE: CHWY) to $28.00 (from $32.00) while maintaining a Outperform rating.

Goldman Sachs discusses Chewy and Petco after retail conference

Tue, 15 Sep 2026 05:16:35 -0400

Investing.com -- Goldman Sachs shared updates on pet retail companies Chewy (NYSE:CHWY) and Petco (NASDAQ:WOOF) following presentations at its 33rd Annual Global Consumer and Retail Conference.

Chewy CEO Sumit Singh said the company expects to continue gaining market share and grow faster than the overall pet category. Singh noted the industry backdrop remains stable but pressured.

The company is expanding beyond traditional pet retail into a broader pet care ecosystem. Investments span Chewy Health, Chewy Vet Care, Modern Animal, pharmacy operations, and additional services. These initiatives aim to attract new customers and increase engagement with existing ones.

Singh identified artificial intelligence, automation, and

Goldman Sachs discusses Chewy and Petco after retail conference

Tue, 15 Sep 2026 05:16:35 -0400

Investing.com -- Goldman Sachs shared updates on pet retail companies Chewy (NYSE:CHWY) and Petco (NASDAQ:WOOF) following presentations at its 33rd Annual Global Consumer and Retail Conference.

Chewy CEO Sumit Singh said the company expects to continue gaining market share and grow faster than the overall pet category. Singh noted the industry backdrop remains stable but pressured.

Singh identified artificial intelligence, automation, and

Chewy Inc. (CHWY) PT Lowered to $30 at Goldman Sachs

Mon, 14 Sep 2026 07:51:47 -0400

Goldman Sachs analyst Alexandra Steiger lowered the price target on Chewy Inc. (NYSE: CHWY) to $30.00 (from $34.00) while maintaining a Buy rating.

Form S-3ASR Chewy, Inc.

Mon, 14 Sep 2026 07:01:00 -0400

si-local-file:///var/storage/secattach/20260914/27055238.html

JPMorgan downgrades Chewy as macro headwinds curb growth

Fri, 11 Sep 2026 08:42:22 -0400

Investing.com -- JPMorgan downgraded Chewy to Neutral from Overweight in a note on Friday, citing persistent macroeconomic pressure on the online pet retailer's organic growth even as the company executes well on its own initiatives.

Analyst Doug Anmuth set a December 2027 price target of $24 for the stock, based on about seven times his 2028 adjusted EBITDA estimate of $1.2 billion.

Chewy shares fell about 9% after its results on Wednesday, against a 1% decline for the S&P 500, as organic growth stayed under pressure and discretionary and premium purchases remained soft in the second quarter.

Despite

JPMorgan downgrades Chewy as macro headwinds curb growth

Fri, 11 Sep 2026 08:42:22 -0400

Analyst Doug Anmuth set a December 2027 price target of $24 for the stock, based on about seven times his 2028 adjusted EBITDA estimate of $1.2 billion.

Despite

Chewy Inc. (CHWY) PT Lowered to $30 at Goldman Sachs

Fri, 11 Sep 2026 06:54:00 -0400

Goldman Sachs analyst Alexandra Steiger lowered the price target on Chewy Inc. (NYSE: CHWY) to $30.00 (from $34.00) while maintaining a Buy rating.

JPMorgan Downgrades Chewy Inc. (CHWY) to Neutral

Fri, 11 Sep 2026 02:54:34 -0400

JPMorgan analyst Doug Anmuth downgraded Chewy Inc. (NYSE: CHWY) from Overweight to Neutral with a price target of $24.00 (from $29.00).

The analyst comments: “CHWY shares are down -9% post-earnings (vs S&P 500 -1%) as organic growth remains under pressure from continued macro headwinds. While the consumer backdrop did not deteriorate further relative to the trends observed exiting 1QFY, it also did not meaningfully recover w/continued pressure across discretionary attachment & premiumization during 2Q. Despite the challenging category backdrop, CHWY continued to gain share in 2Q, outperforming the broader pet category by ~2-3x, & saw healthy customer additions, retention, reactivations, &

JPMorgan Downgrades Chewy Inc. (CHWY) to Neutral

Fri, 11 Sep 2026 02:54:34 -0400

JPMorgan analyst Doug Anmuth downgraded Chewy Inc. (NYSE: CHWY) from Overweight to Neutral with a price target of $24.00 (from $29.00).

Chewy Inc. (CHWY) PT Lowered to $32 at TD Cowen

Thu, 10 Sep 2026 09:35:20 -0400

(Updated - September 10, 2026 9:35 AM EDT)

TD Cowen analyst William Kerr lowered the price target on Chewy Inc. (NYSE: CHWY) to $32.00 (from $34.00) while maintaining a Buy rating.

The analyst commented: "2Q Results Solid But The Outlook for The Pet Market Remains Challenging; 2Q26 revenue was slightly above consensus, while EBITDA beat by ~8% driven by one time items. 3Q EBITDA guide was slightly weaker than expected as mgmt noted ramping ad spend & q/q GM compression. Mgmt. raised FY26 revenue & EBITDA margin guides slightly given 2Q beat. We tweaked our revenue and EBITDA outlook slightly. Shares were

Chewy Inc. (CHWY) PT Lowered to $32 at TD Cowen

Thu, 10 Sep 2026 09:35:20 -0400

(Updated - September 10, 2026 9:35 AM EDT)

TD Cowen analyst William Kerr lowered the price target on Chewy Inc. (NYSE: CHWY) to $32.00 (from $34.00) while maintaining a Buy rating.

Chewy Inc. (CHWY) PT Lowered to $31 at RBC Capital

Thu, 10 Sep 2026 09:17:12 -0400

(Updated - September 10, 2026 9:17 AM EDT)

RBC Capital analyst Steven Shemesh lowered the price target on Chewy Inc. (NYSE: CHWY) to $31.00 (from $34.00) while maintaining an Outperform rating.

The analyst commented: "Gaining Modest Share, but Category Outlook Remains Muted; CHWY delivered top/bottom line beats and inched 2026 guidance higher. We're encouraged by market share gains and LT opportunities from acquisitions, though acknowledge the forward catalyst path remains limited given the current state of the category. We slightly raise our 3Q net sales growth estimate to +7.0% (+6.8% prior / guidance +6.6-7.7%) and move our adj. EBITDA estimate to $221M.

Chewy Inc. (CHWY) PT Lowered to $31 at RBC Capital

Thu, 10 Sep 2026 09:17:12 -0400

(Updated - September 10, 2026 9:17 AM EDT)

RBC Capital analyst Steven Shemesh lowered the price target on Chewy Inc. (NYSE: CHWY) to $31.00 (from $34.00) while maintaining an Outperform rating.

UBS Reiterates Neutral Rating on Chewy Inc. (CHWY) Following Q2 Print

Thu, 10 Sep 2026 09:12:09 -0400

UBS analyst Michael Lasser reiterated a Neutral rating and $24.00 price target on Chewy Inc. (NYSE: CHWY).

The analyst commented, "With each print from CHWY, small changes in perception can lead to outsized moves for the stock. The reality is that the company’s income statement does not change that much. In the case of 2Q, the headline can be deduced to an underwhelming gross margin outcome and slightly lower than expected organic net adds, probably led to modest downside for estimates for 2027. The market interpreted the results as lowering the probability that CHWY can see a meaningful top-line acceleration without

Chewy Inc. (CHWY) PT Lowered to $36 at Morgan Stanley

Thu, 10 Sep 2026 07:59:25 -0400

Morgan Stanley analyst Lauren Schenk lowered the price target on Chewy Inc. (NYSE: CHWY) to $36.00 (from $37.00) while maintaining a Overweight rating.

Chewy Inc. (CHWY) PT Lowered to $24 at Rosenblatt

Thu, 10 Sep 2026 07:12:16 -0400

Rosenblatt analyst Scott Devitt lowered the price target on Chewy Inc. (NYSE: CHWY) to $24.00 (from $25.00) while maintaining a Neutral rating.

Chewy Inc. (CHWY) PT Lowered to $28 at Baird

Thu, 10 Sep 2026 06:19:50 -0400

Baird analyst Justin Kleber lowered the price target on Chewy Inc. (NYSE: CHWY) to $28.00 (from $30.00) while maintaining a Outperform rating.